These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9191533)

  • 21. p53 mutations predict non-small cell lung carcinoma response to radiotherapy.
    Matsuzoe D; Hideshima T; Kimura A; Inada K; Watanabe K; Akita Y; Kawahara K; Shirakusa T
    Cancer Lett; 1999 Jan; 135(2):189-94. PubMed ID: 10096428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
    Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
    Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of point mutations in promoter and coding sequence of p21 gene in a variety of human malignancies].
    Huang Q; Tao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):169-72. PubMed ID: 10837517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
    Yook JI; Kim J
    Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
    Malkowicz SB; Tomaszewski JE; Linnenbach AJ; Cangiano TA; Maruta Y; McGarvey TW
    Oncogene; 1996 Nov; 13(9):1831-7. PubMed ID: 8934528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas.
    Ohashi K; Nemoto T; Eishi Y; Matsuno A; Nakamura K; Hirokawa K
    Virchows Arch; 1997 May; 430(5):389-95. PubMed ID: 9174629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of the cell cycle arrest gene p21WAF1, but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK.
    Ibrahim SO; Lillehaug JR; Dolphine O; Johnson NW; Warnakulasuriya KA; Vasstrand EN
    Anticancer Res; 2002; 22(3):1445-51. PubMed ID: 12168821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of CDKN1A polymorphisms: markers of cancer susceptibility?
    Rodrigues FC; Kawasaki-Oyama RS; Fo JF; Ukuyama EE; Antonio JR; Bozola AR; Romeiro JG; Rahal P; Tajara EH
    Cancer Genet Cytogenet; 2003 Apr; 142(2):92-8. PubMed ID: 12699883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
    Balbín M; Hannon GJ; Pendás AM; Ferrando AA; Vizoso F; Fueyo A; López-Otín C
    J Biol Chem; 1996 Jun; 271(26):15782-6. PubMed ID: 8663132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.
    Papandreou CN; Bogenrieder T; Loganzo F; Albino AP; Nanus DM
    Urology; 1997 Mar; 49(3):481-6. PubMed ID: 9123723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx.
    Nadal A; Jares P; Cazorla M; Fernández PL; Sanjuan X; Hernandez L; Pinyol M; Aldea M; Mallofré C; Muntané J; Traserra J; Campo E; Cardesa A
    J Pathol; 1997 Oct; 183(2):156-63. PubMed ID: 9390027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.